MedTrace Logo

Treatment Outcomes of Retroperitoneal Sarcoma

NCT06612671 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-09-25

No results posted yet for this study

Summary

Investigators tried condult a retrospective study to analysis the prognostic factors and oncological outcome analysis of Retroperitoneal Sarcoma treated in our high volume medical center.

Conditions

  • Retroperitoneal Sarcoma

Interventions

PROCEDURE

tumor wide excision

patients received properative or post-operative radiotherapy

Sponsors & Collaborators

  • Taichung Veterans General Hospital

    lead OTHER

Principal Investigators

  • Radiation-Oncology Department Liu, M.D. · Department of Radiation-Oncology, Taichung Veterans General Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-07-01
Completion
2025-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06612671 on ClinicalTrials.gov